(2022). Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum. Mult Scler, 13524585221094218. http://doi.org/10.1177/13524585221094218.
(2022). Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension. J Psychopharmacol, 2698811221082470. http://doi.org/10.1177/02698811221082470.
(2003). Use of alpha-blockers and the risk of hip/femur fractures. J Intern Med..
(2004). Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart. http://doi.org/10.1136/hrt.2003.020180.
(2006). Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology. http://doi.org/10.1212/01.wnl.0000210503.89488.88.
(2005). Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Epilepsia. http://doi.org/10.1111/j.0013-9580.2005.23804.x.
(2006). Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia. http://doi.org/10.1111/j.1528-1167.2006.00596.x.
(2006). Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax. http://doi.org/10.1136/thx.2006.062885.
(2007). Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands. Calcif Tissue Int. http://doi.org/10.1007/s00223-006-0213-1.
(2006). Difference in risks of allergic reaction to sulfonamide drugs based on chemical structure. Ann Pharmacother. http://doi.org/10.1345/aph.1G642.